Skip to main content

Table 1 Baseline characteristics of participants in cerebral stroke case and healthy control groups

From: Association of MMP3, MMP14, and MMP25 gene polymorphisms with cerebral stroke risk: a case-control study

Characteristics

 

Cases

N = 674

Control

n = 674

p

Age (years)

Mean ± SD

54.85 ± 6.759

55.61 ± 9.130

0.080

 

> 55

377 (55.9%)

295 (43.8%)

 
 

≤ 55

297 (44.1%)

379 (56.2%)

 

Gender

Male

455 (67.5%)

443 (65.5%)

0.488

 

Female

219 (32.5%)

231 (34.3%)

 

Smoking

Yes

319 (47.3%)

323 (47.9%)

0.827

 

No

355 (52.7%)

351 (52.1%)

 

Drinking

Yes

328 (48.7%)

332 (49.3%)

0.827

 

No

346 (51.3%)

342 (50.7%)

 

UA (µmol/L)

 

283.17 ± 89.14

322.45 ± 78.78

0.000*

HDL-C (mmol/L)

 

1.10 ± 0.24

1.15 ± 0.29

0.041*

EOS (%)

 

1.62 ± 1.72

2.28 ± 1.72

0.000*

GLOB (g/L)

 

25.31 ± 3.71

26.18 ± 3.28

0.001*

MON (%)

 

5.58 ± 2.57

7.02 ± 1.87

0.000*

LDL-C (mmol/L)

 

1.97 ± 0.68

2.67 ± 0.73

0.000*

RBC (×1012/L)

 

4.72 ± 0.66

4.87 ± 0.45

0.002*

  1. UA, uric acid; HDL-C, high-density lipoprotein cholesterol; EOS, Eosinophil; GLOB, globulin; MON, monocytes; LDL-C, Low Density Lipoprotein; RBC, red blood cell
  2. p < 0.05, bold text and ‘*’ represent statistical significance